Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
<p>Abstract</p> <p>Background</p> <p>The World Health Organization (WHO) recommends that the cost effectiveness of introducing human papillomavirus (HPV) vaccination is considered before such a strategy is implemented. However, developing countries often lack the techni...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-05-01
|
| Series: | BMC Medicine |
| Online Access: | http://www.biomedcentral.com/1741-7015/9/54 |